Adeptus Health (ADPT) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
July 22, 2016 8:54 AM EDTJefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following the company's 2Q earnings report. Q2 results mostly came in below expectations and at the low end of management's guidance. Jefferies does not expect meaningful... More
